menu
    • menu

    Company profile for Peptilogics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Peptilogics is a clinical-stage biotechnology company developing a new platform technology that enables us to rapidly and effectively develop novel peptide therapeutics for unmet patient needs, with an early focus on anti-infectives. Our therapeutics in development demonstrates the potential for powerful broad-spectrum activity against the most dangerous drug-resistant bacteria, with significantly better resistance profile...
    Peptilogics is a clinical-stage biotechnology company developing a new platform technology that enables us to rapidly and effectively develop novel peptide therapeutics for unmet patient needs, with an early focus on anti-infectives. Our therapeutics in development demonstrates the potential for powerful broad-spectrum activity against the most dangerous drug-resistant bacteria, with significantly better resistance profile and efficacy due to novel mechanisms of action.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PeptilogicsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    700 Technology Drive Suite 4317 Pittsburgh
    Telephone
    Telephone
    (650) 590-9416
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://peptilogics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Peptilogics Reports +ve 90-Day Top Line Data From Ph1b Trial of PLG0206
    Peptilogics Reports +ve 90-Day Top Line Data From Ph1b Trial of PLG0206

    24 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230524005150/en

    BUSINESSWIRE
    24 May 2023
    Share Share
    Peptilogics Completes Phase 1b Trial Enrollment Data of PLG0206
    Peptilogics Completes Phase 1b Trial Enrollment Data of PLG0206

    06 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230406005218/en

    BUSINESSWIRE
    06 Apr 2023
    Share Share
    Peptilogics Hosting Discussion with Experts on High Unmet Medical Need
    Peptilogics Hosting Discussion with Experts on High Unmet Medical Need

    21 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230221005302/en

    BUSINESSWIRE
    21 Feb 2023
    Share Share
    Peptilogics Presents Data of Engineered Peptide PLG0206 at the 2022 ASM/ESCMID
    Peptilogics Presents Data of Engineered Peptide PLG0206 at the 2022 ASM/ESCMID

    07 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221007005082/en

    BUSINESSWIRE
    07 Oct 2022
    Share Share
    Peptilogics doses first subject in periprosthetic joint infection trial
    Peptilogics doses first subject in periprosthetic joint infection trial

    07 Oct 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/peptilogics-periprosthetic-joint-infection-trial/

    CLINICALTRIALSARENA
    07 Oct 2022
    Share Share
    Peptilogics Announces First Patient Dosed in Phase 1b Study of PLG0206
    Peptilogics Announces First Patient Dosed in Phase 1b Study of PLG0206

    06 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221006005192/en

    BUSINESSWIRE
    06 Oct 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search